跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Onsett - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Onsett
Approved
STANDARD
Onsett
Cadila Pharmaceutical Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
af2fcdccf5436cfc
Company
Cadila Pharmaceutical Limited
Type
Standard
Approval Details
Approval Id
af2fcdccf5436cfc
Drug Approval Philippines Name
Onsett
Product Name
Onsett
Registration Number
DRP-5894
Brand Name
Onsett
Generic Name
Ondansetron (as Hydrochloride)
Dosage Form
Solution For Injection (I.M./I.V.)
Dosage Strength
2 mg/mL
Manufacturer
Cadila Pharmaceutical Limited
Importer
Ambica International Corporation
Distributor
Caledan Pharma Corp.
Issuance Date
27 February 2024
Expiry Date
11 December 2029
Pharmacologic Category
Antiemetic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
af2fcdccf5436cfc
Type
Standard
Back to Philippines FDA Approvals